Toker A - Search Results

1

Nonessential amino acid metabolism in breast cancer.

Geck RC, Toker A. Geck RC, et al. Among authors: toker a. Adv Biol Regul. 2016 Sep;62:11-17. doi: 10.1016/j.jbior.2016.01.001. Epub 2016 Jan 21. Adv Biol Regul. 2016. PMID: 26838061 Review.

2

Achieving specificity in Akt signaling in cancer.

Toker A. Toker A. Adv Biol Regul. 2012 Jan;52(1):78-87. doi: 10.1016/j.advenzreg.2011.09.020. Adv Biol Regul. 2012. PMID: 21986444 Free PMC article. Review. No abstract available.

3

Signaling specificity in the Akt pathway in biology and disease.

Toker A, Marmiroli S. Toker A, et al. Adv Biol Regul. 2014 May;55:28-38. doi: 10.1016/j.jbior.2014.04.001. Epub 2014 Apr 19. Adv Biol Regul. 2014. PMID: 24794538 Free PMC article. Review.

4

Signalling specificity in the Akt pathway in breast cancer.

Clark AR, Toker A. Clark AR, et al. Among authors: toker a. Biochem Soc Trans. 2014 Oct;42(5):1349-55. doi: 10.1042/BST20140160. Biochem Soc Trans. 2014. PMID: 25233414 Review.

5

Cross-talk between the CK2 and AKT signaling pathways in cancer.

Ruzzene M, Bertacchini J, Toker A, Marmiroli S. Ruzzene M, et al. Among authors: toker a. Adv Biol Regul. 2017 May;64:1-8. doi: 10.1016/j.jbior.2017.03.002. Epub 2017 Mar 28. Adv Biol Regul. 2017. PMID: 28373060 Review.

6

Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.

Lien EC, Ghisolfi L, Geck RC, Asara JM, Toker A. Lien EC, et al. Among authors: toker a. Sci Signal. 2017 Dec 19;10(510):eaao6604. doi: 10.1126/scisignal.aao6604. Sci Signal. 2017. PMID: 29259101 Free PMC article.

7

Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy.

Geck RC, Foley JR, Murray Stewart T, Asara JM, Casero RA Jr, Toker A. Geck RC, et al. Among authors: toker a. J Biol Chem. 2020 May 8;295(19):6263-6277. doi: 10.1074/jbc.RA119.012376. Epub 2020 Mar 5. J Biol Chem. 2020. PMID: 32139506 Free PMC article.

8

The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer.

Liu H, Paddock MN, Wang H, Murphy CJ, Geck RC, Navarro AJ, Wulf GM, Elemento O, Haucke V, Cantley LC, Toker A. Liu H, et al. Among authors: toker a. Cancer Discov. 2020 Aug;10(8):1226-1239. doi: 10.1158/2159-8290.CD-19-1262. Epub 2020 Jun 8. Cancer Discov. 2020. PMID: 32513774 Free PMC article.

9

Metabolic pathway alterations in microvascular endothelial cells in response to hypoxia.

Cohen EB, Geck RC, Toker A. Cohen EB, et al. Among authors: toker a. PLoS One. 2020 Jul 9;15(7):e0232072. doi: 10.1371/journal.pone.0232072. eCollection 2020. PLoS One. 2020. PMID: 32645038 Free PMC article.

10

FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance.

Li Y, Qiu X, Wang X, Liu H, Geck RC, Tewari AK, Xiao T, Font-Tello A, Lim K, Jones KL, Morrow M, Vadhi R, Kao PL, Jaber A, Yerrum S, Xie Y, Chow KH, Cejas P, Nguyen QD, Long HW, Liu XS, Toker A, Brown M. Li Y, et al. Among authors: toker a. Nat Cell Biol. 2021 Nov;23(11):1187-1198. doi: 10.1038/s41556-021-00781-z. Epub 2021 Nov 4. Nat Cell Biol. 2021. PMID: 34737445

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

446 results

Search Page

Filters